Dr. Reddy's Q3 Earnings Preview
Source: SeekingAlpha
2026-01-20 11:21:13 ET
More on Dr. Reddy's
- Dr. Reddy's: Underappreciated Future Amid Exaggerated Headwinds
- Dr. Reddy's Laboratories Limited (RDY) Q2 2026 Earnings Call Transcript
- Seeking Alpha’s Quant Rating on Dr. Reddy's
- Historical earnings data for Dr. Reddy's
- Dividend scorecard for Dr. Reddy's
Read the full article on Seeking Alpha
For further details see:
Dr. Reddy's Q3 Earnings Preview
Dr. Reddy's Laboratories Ltd
NASDAQ: RDY
RDY Trading
-2.18% G/L:
$13.25 Last:
2,447,390 Volume:
$13.20 Open:
RDY Latest News
February 20, 2026 10:57:00 am
Dr. Reddy's Announces USFDA Acceptance to Review Its Biologics License Application (BLA) for Proposed Interchangeable Biosimilar, Abatacept
RDY Stock Data
$11,719,925,601
612,073,010
N/A
98
N/A
Pharmaceuticals
Healthcare
IN
Hyderabad
